Investigator
Director, Clinical NGS · Memorial Sloan Kettering Cancer Center, Department of Pathology and Laboratory Medicine
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Emergence of drug resistance is the main cause of therapeutic failure in patients with high-grade serous ovarian cancer (HGSOC)
Director, Clinical NGS
Memorial Sloan Kettering Cancer Center · Department of Pathology and Laboratory Medicine
Mgr.,CMO Technology Innovation
Sloan Kettering Institute · Cmo operation
US
